Literature DB >> 16981789

Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy.

James S Welsh1, Michael Lock, Paul M Harari, Wolfgang A Tomé, Jack Fowler, Thomas Rockwell Mackie, Mark Ritter, Jeff Kapatoes, Lisa Forrest, Richard Chappell, Bhudatt Paliwal, Minesh P Mehta.   

Abstract

Image-guided IMRT is a revolutionary concept whose clinical implementation is rapidly evolving. Methods of executing beam intensity modulation have included individually designed compensators, static multi-leaf collimators (MLC), dynamic MLC, and sequential (serial) tomotherapy. We have developed helical tomotherapy as an innovative solution to overcome some of the limitations of other IMRT systems. The unique physical design of helical tomotherapy allows the realization of the concepts of adaptive radiotherapy and conformal avoidance. In principle, these advances should improve normal tissue sparing and permit dose reconstruction and verification, thereby allowing significant biologically effective dose escalation. Recent radiobiological findings can be translated into altered fractionation schemes that aim to improve the local control and long-term survival. This strategy is being tested at the University of Wisconsin using helical tomotherapy with its highly precise delivery and verification system along with meticulous and practical forms of immobilization. Innovative techniques such optical guidance, respiratory gating, and ultrasound assessments are being designed and tailored for helical tomotherapy use. The intrinsic capability of helical tomotherapy for megavoltage CT (MVCT) imaging for IMRT image-guidance is being optimized. The unique features of helical tomotherapy might allow implementation of image-guided IMRT that was previously impossible or impractical. Here we review the technological, physical, and radiobiological rationale for the ongoing and upcoming clinical trials that will use image-guided IMRT in the form of helical tomotherapy; and we describe our plans for testing our hypotheses in a rigorous prospective fashion.

Mesh:

Year:  2006        PMID: 16981789     DOI: 10.1177/153303460600500503

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  20 in total

1.  Feasibility of intrafraction whole-body motion tracking for total marrow irradiation.

Authors:  Manju Sharma; Troy Dos Santos; Nikolaos P Papanikolopoulos; Susanta Kumar Hui
Journal:  J Biomed Opt       Date:  2011-05       Impact factor: 3.170

2.  Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy.

Authors:  Jessica A Lawrence; Lisa J Forrest; Michelle M Turek; Paul E Miller; T Rockwell Mackie; Hazim A Jaradat; David M Vail; Richard R Dubielzig; Richard Chappell; Minesh P Mehta
Journal:  Vet Radiol Ultrasound       Date:  2010 Sep-Oct       Impact factor: 1.363

3.  Three-dimensional patient setup errors at different treatment sites measured by the Tomotherapy megavoltage CT.

Authors:  S K Hui; E Lusczek; T DeFor; K Dusenbery; S Levitt
Journal:  Strahlenther Onkol       Date:  2012-03-09       Impact factor: 3.621

4.  Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer.

Authors:  M N Duma; S Kampfer; T Schuster; C Winkler; H Geinitz
Journal:  Strahlenther Onkol       Date:  2012-03       Impact factor: 3.621

5.  Evaluation on lung cancer patients' adaptive planning of TomoTherapy utilising radiobiological measures and Planned Adaptive module.

Authors:  Fan-Chi Su; Chengyu Shi; Panayiotis Mavroidis; Prema Rassiah-Szegedi; Niko Papanikolaou
Journal:  J Radiother Pract       Date:  2009-01-01

6.  A survey of image-guided radiation therapy use in the United States.

Authors:  Daniel R Simpson; Joshua D Lawson; Sameer K Nath; Brent S Rose; Arno J Mundt; Loren K Mell
Journal:  Cancer       Date:  2010-08-15       Impact factor: 6.860

7.  The value of image-guided intensity-modulated radiotherapy in challenging clinical settings.

Authors:  S J Treece; M Mukesh; Y L Rimmer; S J Tudor; J C Dean; R J Benson; D L Gregory; G Horan; S J Jefferies; S G Russell; M V Williams; C B Wilson; N G Burnet
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

8.  Dosimetric validation of first helical tomotherapy Hi-Art II machine in India.

Authors:  Rajesh A Kinhikar; Swamidas V Jamema; Rajeshri Pai; Master Zubin; Tejpal Gupta; Deepak S Dhote; Deepak D Deshpande; Shyam K Shrivastava; Rajiv Sarin
Journal:  J Med Phys       Date:  2009-01

9.  Localization and quantification of the delivered dose to the spinal cord. Predicting actual delivered dose during daily MVCT image-guided tomotherapy.

Authors:  M N Duma; T Schuster; N Aswathanarayana; L-S Fromm; M Molls; H Geinitz; S Kampfer
Journal:  Strahlenther Onkol       Date:  2013-10-10       Impact factor: 3.621

10.  Initial dosimetric experience with mega voltage computed tomography detectors and estimation of pre and post-repair dosimetric parameters of a first Helical Hi-Art II tomotherapy machine in India.

Authors:  Rajesh A Kinhikar; Zubin Master; Dipak S Dhote; Deepak D Deshpande
Journal:  J Med Phys       Date:  2009-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.